Wedge Capital Management
RYTM icon

Wedge Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Wedge Capital Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.21M Sell
23,259
-163
-0.7% -$17.4K 0.04% 316
2026
Q2 		$2.6M Sell
23,422
-1,113
-5% -$101K 0.04% 288
2026
Q1 		$2.13M Buy
24,535
+5,288
+27% +$514K 0.04% 335
2025
Q4 		$2.06M Sell
19,247
-2,997
-13% -$318K 0.04% 340
2025
Q3 		$2.25M Sell
22,244
-7,747
-26% -$719K 0.04% 331
2025
Q2 		$1.9M Sell
29,991
-6,993
-19% -$428K 0.03% 331
2025
Q1 		$1.96M Sell
36,984
-11,427
-24% -$634K 0.04% 329
2024
Q4 		$2.71M Sell
48,411
-433
-0.9% -$23.9K 0.05% 286
2024
Q3 		$2.56M Sell
48,844
-14,353
-23% -$688K 0.04% 292
2024
Q2 		$2.59M Sell
63,197
-10,676
-14% -$426K 0.05% 283
2024
Q1 		$3.2M Sell
73,873
-2,634
-3% -$115K 0.05% 278
2023
Q4 		$3.52M Sell
76,507
-28,213
-27% -$890K 0.06% 270
2023
Q3 		$2.4M Sell
104,720
-113,705
-52% -$2.55M 0.05% 291
2023
Q2 		$3.6M Buy
+218,425
New +$3.94M 0.06% 312

Other funds holding RYTM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Cannon Financial Strategists
Cannon Financial Strategists Athens, Georgia $885M AUM 13.17% 1-Year Est. Return
Aspiriant LLC
Aspiriant LLC Los Angeles, California $4.08B AUM 12.02% 1-Year Est. Return
Toth Financial Advisory
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
E. Ohman J:or Asset Management
E. Ohman J:or Asset Management Stockholm, Sweden $4.47B AUM 27.58% 1-Year Est. Return
Avior Wealth Management
Avior Wealth Management Omaha, Nebraska $3.79B AUM 15.36% 1-Year Est. Return
Abel Hall LLC
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return
Inspire Investing
Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return
Mitsubishi UFJ Asset Management (UK)
Mitsubishi UFJ Asset Management (UK) London, United Kingdom $213M AUM 36.38% 1-Year Est. Return

Wedge Capital Management's RYTM Position: Q3 2026 in Review

Wedge Capital Management reduced its Rhythm Pharmaceuticals (RYTM) stake by 0.7% in Q3 2026, selling an estimated $17.4K and leaving 23,259 shares worth $2.21M. The position accounts for 0.04% of the portfolio, ranked #316.

Wedge Capital Management first reported a position in RYTM in Q2 2023 and has held it in 14 quarters since. The position peaked at $3.6M in Q2 2023. 37 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

  • Wedge Capital Management held 23,259 shares of Rhythm Pharmaceuticals worth $2.21M as of Q3 2026.
  • Wedge Capital Management sold 163 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $17.4K.
  • Rhythm Pharmaceuticals made up 0.04% of Wedge Capital Management's portfolio in Q3 2026, its #316 holding.
  • Wedge Capital Management first reported a position in Rhythm Pharmaceuticals in Q2 2023 and has held it in 14 quarters since.
  • Wedge Capital Management's Rhythm Pharmaceuticals position peaked at $3.6M in Q2 2023.
  • 37 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on Wedge Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.